135 related articles for article (PubMed ID: 1089142)
1. Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long-term alternate-day prednisone therapy.
McAdams AJ; McEnery PT; West CD
J Pediatr; 1975 Jan; 86(1):23-31. PubMed ID: 1089142
[TBL] [Abstract][Full Text] [Related]
2. The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis.
McEnery PT; McAdams AJ; West CD
Medicine (Baltimore); 1985 Nov; 64(6):401-24. PubMed ID: 2414636
[TBL] [Abstract][Full Text] [Related]
3. Regression of dense deposits in Type II membranoproliferative glomerulonephritis: case report of clinical course in a child.
Kher KK; Makker SP; Aikawa M; Kirson IJ
Clin Nephrol; 1982 Feb; 17(2):100-3. PubMed ID: 7067166
[TBL] [Abstract][Full Text] [Related]
4. Mesangial proliferative glomerulonephritis with irregular intramembranous deposits. Another variant of hypocoplementemic nephritis.
Davis AE; Schneeberger EE; McCluskey RT; Grupe WE
Am J Med; 1977 Sep; 63(3):481-7. PubMed ID: 331950
[TBL] [Abstract][Full Text] [Related]
5. Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy.
McEnery PT; McAdams AJ; West CD
Clin Nephrol; 1980 Mar; 13(3):117-24. PubMed ID: 7379361
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
Venkataseshan VS; Lieberman K; Kim DU; Thung SN; Dikman S; D'Agati V; Susin M; Valderrama E; Gauthier B; Prakash A
Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
[TBL] [Abstract][Full Text] [Related]
7. Azathioprine in glomerulonephritis. A long-term study.
McIntosh RM; Griswold W; Smith FG; Kaufman DB; Urizar R; Vernier RL
Lancet; 1972 May; 1(7760):1085-9. PubMed ID: 4112570
[No Abstract] [Full Text] [Related]
8. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
Strife CF; McAdams AJ; West CD
Clin Nephrol; 1982 Jul; 18(1):9-16. PubMed ID: 6749363
[TBL] [Abstract][Full Text] [Related]
9. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
Cruse JM; Lewis RE; Dilioglou S
Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362
[TBL] [Abstract][Full Text] [Related]
10. [Delayed healing process and exacerbation of a diffuse intra- and extracapillary glomerulonephritis with IgA-deposits (clinical, light-, electron- and immunofluorescent-microscopic examinations of sequential biopsies)].
Zollinger HU; Gaboardi F
Virchows Arch A Pathol Pathol Anat; 1971; 354(4):349-60. PubMed ID: 5316274
[No Abstract] [Full Text] [Related]
11. Spontaneous mesangiocapillary glomerulonephritis in Finn cross lambs from Alberta.
Frelier PF; Pritchard J; Armstrong DL; Nagge WT; Lewis RM
Can J Comp Med; 1984 Apr; 48(2):215-8. PubMed ID: 6372972
[TBL] [Abstract][Full Text] [Related]
12. Type III membranoproliferative glomerulonephritis: long-term clinical and morphologic evaluation.
Strife CF; Jackson EC; McAdams AJ
Clin Nephrol; 1984 Jun; 21(6):323-34. PubMed ID: 6331934
[TBL] [Abstract][Full Text] [Related]
13. Extramembranous glomerulonephritis in children: report of 50 cases.
Habib R; Kleinknecht C; Gubler MC
J Pediatr; 1973 May; 82(5):754-66. PubMed ID: 4572936
[No Abstract] [Full Text] [Related]
14. Progression from minimal or focal to diffuse proliferative lupus nephritis.
Zimmerman SW; Jenkins PG; Shelf WD; Bloodworth JM; Burkholder PM
Lab Invest; 1975 May; 32(5):665-72. PubMed ID: 1092911
[TBL] [Abstract][Full Text] [Related]
15. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine and prednisone in the treatment of adults with lupus nephritis. Clinical, histological, and immunological changes with therapy.
Drinkard JP; Stanley TM; Dornfeld L; Austin RC; Barnett EV; Pearson CM; Vernier RL; Adams DA; Latta H; Gonick HC
Medicine (Baltimore); 1970 Sep; 49(5):411-32. PubMed ID: 4924695
[No Abstract] [Full Text] [Related]
17. Regression of membranoproliferative glomerulonephritis type II (dense deposit disease): observations in six children.
McEnery PT; McAdams AJ
Am J Kidney Dis; 1988 Aug; 12(2):138-46. PubMed ID: 3400634
[TBL] [Abstract][Full Text] [Related]
18. Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. II. Influence of medication with prednisone and azathioprine: a histologic and immunohistologic study at the light microscopic and the ultrastructural level.
Feenstra K; van den Lee R; Greben HA; Arends A; Hoedemaeker PJ
Lab Invest; 1975 Feb; 32(2):243-50. PubMed ID: 1089843
[TBL] [Abstract][Full Text] [Related]
19. Monocyte infiltration in human glomerulonephritis: alpha-1-antitrypsin as a marker for mononuclear phagocytes in renal biopsies.
Laohapand T; Cattell V; Gabriel JR
Clin Nephrol; 1983 Jun; 19(6):309-16. PubMed ID: 6347490
[TBL] [Abstract][Full Text] [Related]
20. [Effect of immunosuppressive, anticoagulant and anti-inflammatory agents on experimental glomerulonephritis. VI. Encorton, immuran and cyclophosphamide].
Tyszkiewicz Z; Gawlik Z; Lewandowska T; Juska D
Patol Pol; 1984; 35(1):105-14. PubMed ID: 6493817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
